Medications Date Route of Mechanism of Indication Contraindication Client’s Response Nursing

Ordered/ Administration/ Action Responsibilities

Given/ Dosage/
Taken Frequency
Generic: April 11, Dosage/ Promotes Prevention ✓ Avoid P.O. use Adverse effect: Prior:
Phytonadione 2022, Frequency: hepatic and in disorders that Hyperbilirubinemia ➢ Explain the
(vitamin K1) administered 0.5 ml synthesis of treatment of may (in infants); with procedure
2 hours of active hemorrhagic prevent parenteral to
Brand: age. Route: prothrombin, disease of adequate administration— significant
Mephyton Left vastus proconvertin, the newborn absorption. pain, swelling, others.
lateralis plasma ✓ Use cautiously tenderness at the ➢ Vitamin K
Classification: Intramuscular thromboplastin in pregnant or injection site; itchy gave before
Vitamin component, breastfeeding rash after repeated the
and Stuart patients, injections; transient circumcision
factor children, and flushing sensations; procedure.
neonates peculiar taste; ➢ Document
(if the product anaphylactoid the
contains benzyl reactions administrat
alcohol). ion of the
✓ Contraindicated drug to
in Side Effects: newborns
hypersensitivity to avoid
to the drug or its Pain and edema accidental
components. may occur at the double
(Life- injection site. doses
threatening Allergic reactions
reactions such as rash and During:
resembling urticaria may also
hypersensitivity occur. ➢ Apply
or anaphylaxis pressure to
have occurred the injection
during and site to
immediately prevent
after I.V. further
injection.) bleeding
After:
➢ Observe
signs of
local
inflammati
on.
➢ Check for
bleeding
(usually on
the 2nd or
3rd day).
Bleeding
can be seen
as common
ecchymosis
or bleeding
from the
umbilical
cord,
circumcisio
n site, nose,
or
gastrointest
inal tract
➢ Observe for
jaundice
and
kernicterus.